- Home
- PROK vs CCRN Comparison
PROK vs CCRN Comparison
Compare PROK & CCRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PROK | CCRN |
|---|---|---|
| Founded | 2015 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 331.2M | 270.9M |
| IPO Year | 2021 | 2001 |
Fundamental Metrics
Financial Performance| Metric | PROK | CCRN |
|---|---|---|
| Price | $2.23 | $9.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | $7.40 | ★ $13.15 |
| AVG Volume (30 Days) | 493.9K | ★ 538.7K |
| Earning Date | 01-01-0001 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $76,000.00 | ★ $816,484,000.00 |
| Revenue This Year | $1,010.19 | N/A |
| Revenue Next Year | N/A | $4.35 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.46 | $7.43 |
| 52 Week High | $7.13 | $15.63 |
Technical Indicators
Market Signals| Indicator | PROK | CCRN |
|---|---|---|
| Relative Strength Index (RSI) | 48.91 | 53.85 |
| Support Level | $2.09 | $7.68 |
| Resistance Level | $2.58 | $9.40 |
| Average True Range (ATR) | 0.16 | 0.45 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 16.28 | 43.90 |
Price Performance
Historical ComparisonAbout PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About CCRN Cross Country Healthcare Inc. $0.0001 Par Value
Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.